Why does hepatitis B remain underprioritized? A view through lived experience. [PDF]
Ibrahim Y +10 more
europepmc +1 more source
A bibliometric analysis of immunotherapy for chronic hepatitis B: trends and hotspots prediction. [PDF]
Jin X, Tang Y, Ma Y, Li M, Gao Y.
europepmc +1 more source
Smart nanoparticle vaccines integrate nanotechnology artificial intelligence and immunoengineering for precision immunization. [PDF]
Morshedi I +8 more
europepmc +1 more source
Decoding HBV-specific adaptive immunity: from natural clearance to cure. [PDF]
Thimme R +3 more
europepmc +1 more source
Primary Cancer Prevention Through Vaccination: Advances, Challenges, and Global Perspectives. [PDF]
Tague C +5 more
europepmc +1 more source
Mathematical modeling of HBV-HDV transmission with superinfection: The role of vaccination and liver transplantation in disease dynamics. [PDF]
Aldila D +3 more
europepmc +1 more source
"Innovative diagnostics and treatments of infections in transplantation," report from the 2025 <i>spring highlights in transplantation sciences</i> meeting. [PDF]
Fourgeaud J +15 more
europepmc +1 more source
Self-reported hepatitis B diagnoses and vaccination history in trans and non-binary communities in Germany, the TASG-study* 2022. [PDF]
Biallas R +9 more
europepmc +1 more source
Targeting cccDNA for Degradation: Endogenous- and Exogenous-Based Methods of Nuclear-Localized DNA Destruction in the Context of Chronic Hepatitis B Infection. [PDF]
Thompson C, Meier-Stephenson V.
europepmc +1 more source
Infection-driven cancers in Asia: implications from epidemiological transitions. [PDF]
Lin Y, Inoue M.
europepmc +1 more source

